This metabolic reprogramming enables GAS6 + macrophages to interact with TEAD3 + melanoma cells via the GAS6-TYRO3 ligand-receptor axis, promoting tumor proliferation, EMT, and metastasis. This evidence concerns the gene GAS6 and melanoma.